Sanofi was voted as the ‘Leading Pan-European Quoted Company for Investor Relations’ in the 2012 Thomson Reuters Extel Survey. The survey highlights achievement across companies listed in Europe.
For the third year in a row, Sanofi was voted first in the European pharmaceuticals and biotechnology sector and first among CAC 40 companies. In the 2009 Extel Survey, Sanofi was included for the first time in the list of Top 100 Pan-European Quoted Companies for IR, ranking in 35th place. In 2010, Sanofi finished in the fifth place and last year, the company was ranked second.
“This Extel award is a fantastic achievement for Sanofi and reflects the considerable efforts by management and the investor relations team to actively engage with the financial community. We thank investors and analysts for their votes. Our award recognises the high-quality dialogue between the company and the financial community and underscores Sanofi’s commitment to excellence in investor relations,” said Christopher A Viehbacher, Chief Executive Officer, Sanofi.
EP News Bureau – Mumbai